
NCPA Applauds Reintroduced Pharmacists Fight Back Act
Key Takeaways
- The Pharmacists Fight Back Act targets PBM reform, focusing on pharmacy reimbursement and penalties for PBM violations.
- It proposes reforms in federal health programs, banning patient steering, and redirecting PBM rebates to reduce premiums.
ALEXANDRIA, Va. (Dec. 12, 2025) – The National Community Pharmacists Association is pleased to support the Pharmacists Fight Back Act, which was reintroduced yesterday by Reps. Jake Auchincloss (D-Mass.), James Comer (R-Ky.), and Diana Harshbarger (R-Tenn.). NCPA was proud to endorse this legislation when it was first introduced last year. It joins other significant PBM reform bills that are currently pending in Congress, such as the PBM Reform Act (H.R. 4317) and the PBM Price Transparency and Accountability Act (S. 3345), which include the PBM reforms that nearly passed last December in the original Continuing Resolution package.
The Pharmacists Fight Back Act aims to address pharmacy reimbursement and provide significant penalties for PBM violations. Among other things, it would reform payments in federal health programs — including Medicare, Medicaid, and the Federal Employees Health Benefits Program — by requiring reimbursements that are based on acquisition costs and fair dispensing fees. It would also ban patient steering and allows for patients to choose their pharmacy, and redirect PBM rebates to the patients and plan sponsors to decrease premiums. These commonsense reforms are paired with robust enforcement on PBM compliance. The bill numbers are H.R. 6609 and H.R. 6610 respectively.
“With this legislation and the other legislative proposals introduced in Congress, legislators have many options at their disposal to check the PBMs — and no reason to delay,” says NCPA CEO Douglas Hoey. “PBM reform would rein in the big health insurance lobby, make prescription drugs more affordable for consumers, and throw a lifeline to the thousands of small, family-owned pharmacies that are on the brink of closure. We are continuing to push hard, along with our allies, for Congress to finalize PBM reform legislation and send it to the president’s desk as soon as possible.”
Auchincloss, Comer, and Harshbarger led the introduction of the Pharmacists Fight Back Act yesterday with a press conference on the lawn of the Capitol where they were also joined by cosponsoring Reps. Buddy Carter (R-Ga.), Sanford Bishop (D-Ga.), and Rashida Tlaib (D-Mich.) as well as pharmacists from 17 states across the country. The representatives and pharmacists spoke on the challenges pharmacists deal with daily and the dire need for PBM reform.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
















































































































































































































